ARATANA THERAPEUTICS INC's ticker is PETX and the CUSIP is 03874P101. A total of 108 filers reported holding ARATANA THERAPEUTICS INC in Q4 2016. The put-call ratio across all filers is 93.00 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,110,000 | +207.1% | 408,889 | +114.3% | 0.00% | +100.0% |
| Q1 2019 | $687,000 | +58.7% | 190,789 | +169.9% | 0.00% | – |
| Q4 2018 | $433,000 | -71.9% | 70,689 | -73.2% | 0.00% | -100.0% |
| Q3 2018 | $1,542,000 | -63.2% | 264,100 | -72.6% | 0.00% | 0.0% |
| Q2 2018 | $4,195,000 | +63.0% | 965,100 | +65.3% | 0.00% | -33.3% |
| Q1 2018 | $2,574,000 | +292.4% | 583,700 | +367.7% | 0.00% | +200.0% |
| Q4 2017 | $656,000 | +33.3% | 124,800 | +55.6% | 0.00% | 0.0% |
| Q3 2017 | $492,000 | -21.8% | 80,200 | -8.5% | 0.00% | 0.0% |
| Q4 2016 | $629,000 | -37.2% | 87,608 | -18.2% | 0.00% | -50.0% |
| Q3 2016 | $1,002,000 | -34.6% | 107,100 | -55.9% | 0.00% | -33.3% |
| Q2 2016 | $1,533,000 | +1402.9% | 242,600 | +1218.5% | 0.00% | – |
| Q1 2016 | $102,000 | -95.1% | 18,400 | -95.1% | 0.00% | -100.0% |
| Q4 2015 | $2,074,000 | – | 371,773 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| March Altus Capital Management LP | 218,515 | $2,045,000 | 12.79% |
| Broadfin Capital, LLC | 3,085,979 | $28,885,000 | 2.59% |
| First Light Asset Management, LLC | 467,743 | $4,378,000 | 1.88% |
| AWM Investment Company, Inc. | 1,005,000 | $9,407,000 | 1.72% |
| MPM ASSET MANAGEMENT LLC | 250,000 | $2,340,000 | 0.77% |
| Grandeur Peak Global Advisors, LLC | 394,450 | $3,692,000 | 0.72% |
| TURNER INVESTMENTS LLC | 208,660 | $1,953,000 | 0.65% |
| WALL STREET ASSOCIATES | 197,400 | $1,848,000 | 0.63% |
| TFS CAPITAL LLC | 192,848 | $1,805,000 | 0.43% |
| GENERAL AMERICAN INVESTORS CO INC | 412,101 | $3,857,000 | 0.39% |